Skip to content

US · UG · HOUSEHOLD & PERSONAL PRODUCTS

United-Guardian, Inc. (UG) intrinsic value and stock valuation

$7.35as of 2026-11-21 · Mkt cap 33.13M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

United-Guardian, Inc. DCF and intrinsic value

InvestorsCraft values UG with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from UG’s statements →

United-Guardian, Inc. Graham Number

Graham Number: $5.03d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Consumer Defensive · Household & Personal Products Hauppauge, NY 11788 u-g.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$10.6M-0.8% 5y CAGRd
20112025
Net income
$2.11M-8.6% 5y CAGRd
20112025
Free cash flow
$1.91M-11.7% 5y CAGRd
20112025
Total equity
$11.2M+1.6% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$10.6M$12.2M$10.9M$12.7M$13.9M
Operating income$2.24M$3.65M$2.86M$4.04M$5.67M
Net income$2.11M$3.25M$2.58M$2.57M$4.66M
EPSd$459.7K$708.1K$562.1K$559.9K$1.02M
Operating cash flow$1.97M$3.47M$3.14M$2.53M$5.31M
Capital expenditure-$-60K-$-430K-$-170K-$-80K-$-120K
Free cash flow$1.91M$3.03M$2.98M$2.45M$5.2M
Total assets$13.1M$13.8M$12.9M$10.6M$12.2M
Total debt$0.00$0.00$0.00$0.00$0.00
Net debt-$-1.25M-$-1.88M-$-8.24M-$-830K-$-530K
Total equity$11.2M$11.9M$11.4M$9.27M$9.82M
Cash and short-term investments$8.57M$9.4M$9.09M$6.48M$8.17M
Income statement
20252024202320222021
Revenue$10.6M$12.2M$10.9M$12.7M$13.9M
Cost of revenue$5.51M$5.72M$5.48M$6M$5.75M
Gross profit$5.03M$6.46M$5.41M$6.7M$8.18M
Research and development expenses$460K$460K$460K$490K$480K
Selling, general and administrative expenses$0.00$0.00$0.00$0.00$0.00
Other expenses$2.33M$2.36M$2.08M$2.17M$2.04M
Operating expenses$2.79M$2.81M$2.54M$2.66M$2.51M
Cost and expenses$8.3M$8.54M$8.02M$8.66M$8.26M
Interest income$370K$430K$310K$240K$230K
Interest expense$0.00$0.00$0.00$1.62M$0.00
Depreciation and amortization$110K$100K$110K$140K$150K
Ebitda$2.75M$4.2M$3.36M$4.98M$6.02M
Operating income$2.24M$3.65M$2.86M$4.04M$5.67M
Total other income/expenses, net$400K$460K$390K-$-810K$210K
Income before tax$2.64M$4.11M$3.25M$3.23M$5.88M
Income tax expense$540K$860K$670K$660K$1.22M
Net income$2.11M$3.25M$2.58M$2.57M$4.66M
Weighted average shares outstanding$4.59M$4.59M$4.59M$4.59M$4.59M
Weighted average diluted shares outstanding$4.59M$4.59M$4.59M$4.59M$4.59M
Balance sheet
20252024202320222021
Cash and short-term investments$8.57M$9.4M$9.09M$6.48M$8.17M
Net receivables$1.59M$1.43M$1.57M$1.43M$1.81M
Inventory$1.51M$1.45M$1.22M$1.67M$1.41M
Total current assets$12.2M$12.7M$12.3M$9.97M$11.6M
Property, plant and equipment, net$910K$960K$620K$560K$660K
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$910K$1.13M$670K$670K$660K
Total assets$13.1M$13.8M$12.9M$10.6M$12.2M
Accounts payable$480K$430K$130K$30K$410K
Short-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue$10K$0.00$20K$0.00$190K
Total current liabilities$1.67M$1.91M$1.53M$1.37M$2.34M
Long-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$210K$0.00$0.00$0.00$80K
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$1.88M$1.91M$1.53M$1.37M$2.42M
Common stock$460K$460K$460K$460K$460K
Retained earnings$10.8M$11.4M$10.9M$8.81M$9.36M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$11.2M$11.9M$11.4M$9.27M$9.82M
Total investments$7.32M$7.52M$850K$5.65M$7.64M
Total debt$0.00$0.00$0.00$0.00$0.00
Net debt-$-1.25M-$-1.88M-$-8.24M-$-830K-$-530K
Cash flow statement
20252024202320222021
Net income$2.11M$3.25M$2.58M$2.57M$4.66M
Depreciation and amortization$110K$100K$110K$140K$150K
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital-$-600K$290K$510K-$-1.06M$560K
Accounts receivable-$-160K$140K-$-140K$390K-$-430K
Inventory-$-50K-$-210K$470K-$-290K$0.00
Accounts payable$60K$290K$100K-$-380K$380K
Net cash provided by operating activities$1.97M$3.47M$3.14M$2.53M$5.31M
Investments in property, plant and equipment-$-60K-$-430K-$-170K-$-80K-$-120K
Acquisitions, net$0.00$0.00$0.00$40K$120K
Net cash used for investing activities$180K-$-7.08M$4.73M$900K-$-180K
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid-$-2.77M-$-2.76M-$-460K-$-3.12M-$-5.19M
Net cash used for financing activities-$-2.77M-$-2.76M-$-460K-$-3.12M-$-5.19M
Net change in cash-$-620K-$-6.37M$7.41M$300K-$-60K
Cash at end of period$1.25M$1.88M$8.24M$830K$530K
Operating cash flow$1.97M$3.47M$3.14M$2.53M$5.31M
Capital expenditure-$-60K-$-430K-$-170K-$-80K-$-120K
Free cash flow$1.91M$3.03M$2.98M$2.45M$5.2M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About United-Guardian, Inc.

        United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.

        CEO
        Donna Vigilante
        Employees
        25
        Beta
        0.96

        Explore

        Frequently asked questions

        What is the intrinsic value of United-Guardian, Inc. (UG)?

        InvestorsCraft does not currently publish an intrinsic value for UG. How the IC value is calculated.

        Is UG undervalued?

        InvestorsCraft does not publish an undervaluation signal for UG at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.